Eikon Therapeutics, Inc. (EIKN) KPIs and segments
EIKNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$5.15−0.23 (-4.36%)
Close on Nov 17, 2026Market cap $278.95MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Eikon Therapeutics's business
Coming soon
This tab will track the numbers specific to Eikon Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?